Screener
Emergent Biosolutions EBS Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $140.9M-48.0% | $161.5M+5.7% | $209.1M+98.0% | $249.2M+59.3% | $271M+282% | ||
| $190M+138% | $121.6M-40.3% | $84.2M-45.5% | $149.5M+23.2% | $79.8M-59.3% | ||
| $303.6M-10.3% | $327.6M+4.3% | $343.4M+10.2% | $356.3M+10.4% | $338.6M+6.6% | ||
| $666M-7.4% | $637.6M-9.8% | $662.5M+10.7% | $786.9M+19.0% | $719.5M+9.9% | ||
| $178M-17.6% | $199.4M-9.8% | $205.4M-24.1% | $209.8M-24.6% | $216.1M-29.4% | ||
| $261.8M-44.2% | $470.4M-3.1% | $436.5M-13.0% | $452.7M-12.6% | $469M-12.2% | ||
| $1.12B-21.2% | $1.32B-7.4% | $1.32B-5.1% | $1.46B-1.1% | $1.42B-6.4% | ||
| $50.2M-21.2% | $39.5M-32.0% | $55.6M-8.7% | $57.4M-30.1% | $63.7M-33.6% | ||
| $15M+206% | $12.2M+171% | $5M+4.2% | $6.1M-16.4% | $4.9M-21.0% | ||
| $122.8M-3.4% | $148.7M+32.9% | $132.2M-18.6% | $136.5M-40.6% | $127.1M-79.5% | ||
| $581.8M-12.9% | $573.6M-13.8% | $572.1M-13.8% | $663.1M+0.2% | $667.8M+49.4% | ||
| $12.8M+33.3% | $13.3M+98.5% | $21.7M+34.0% | $14.4M+3.6% | $9.6M+123% | ||
| 200M0.0% | 200M0.0% | 200M+199,900% | 200M0.0% | 200M0.0% | ||
| -$333.2M-113% | -$153M-6.0% | -$159.8M+24.8% | -$105.2M+41.9% | -$156.4M+47.1% | ||
| $341.4M-36.3% | $523.1M-5.4% | $522.6M+8.2% | $582.5M+14.6% | $536.2M+38.8% | ||
| $1.12B-21.2% | $1.32B-7.4% | $1.32B-5.1% | $1.46B-1.1% | $1.42B-6.4% |
FAQ
- What are Emergent Biosolutions's total assets?
- Emergent Biosolutions (EBS) holds $1.1B in total assets, down 21.2% year over year.
- How much debt does Emergent Biosolutions have?
- Emergent Biosolutions carries $588.2M in total debt against $341.4M of shareholders' equity, a debt-to-equity ratio of 1.72.
- How much cash does Emergent Biosolutions have?
- Emergent Biosolutions holds $140.9M in cash and equivalents.
- Can Emergent Biosolutions cover its short-term obligations?
- Its current ratio is 5.42 — current assets exceed current liabilities.
- Where does Emergent Biosolutions's balance sheet data come from?
- Every line is extracted from Emergent Biosolutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
